David Keith Simon

Affiliations: 
Beth Israel Deaconess Medical Center, Boston, MA, United States 
Area:
Parkinson's Disease, Mitochondrial Genetics
Google:
"David Simon"
Mean distance: 17.38 (cluster 28)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Iwaki H, Blauwendraat C, Leonard HL, et al. (2020) Differences in the Presentation and Progression of Parkinson's Disease by Sex. Movement Disorders : Official Journal of the Movement Disorder Society
Cutillo G, Simon DK, Eleuteri S. (2020) VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology. Neurobiology of Disease. 145: 105056
Simon DK, Tanner CM, Brundin P. (2020) Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine. 36: 1-12
Iwaki H, Blauwendraat C, Leonard HL, et al. (2019) Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. Movement Disorders : Official Journal of the Movement Disorder Society
Espay AJ, Vizcarra JA, Marsili L, et al. (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337
Quansah E, Peelaerts W, Langston JW, et al. (2018) Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration. Molecular Neurodegeneration. 13: 28
Gibbons CH, Simon DK, Huang M, et al. (2017) Autonomic and electrocardiographic findings in Parkinson's disease. Autonomic Neuroscience : Basic & Clinical
Chou KL, Elm JJ, Wielinski CL, et al. (2017) Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort. Journal of the Neurological Sciences. 377: 137-143
Simon DK, Matott JC, Espinosa J, et al. (2017) Mitochondrial DNA mutations in Parkinson's disease brain. Acta Neuropathologica Communications. 5: 33
Simon DK, Wu C, Tilley BC, et al. (2017) Caffeine, creatine, GRIN2A and Parkinson's disease progression. Journal of the Neurological Sciences. 375: 355-359
See more...